Detalhe da pesquisa
1.
Phase I Study of Lenalidomide and Sorafenib in Patients With Advanced Hepatocellular Carcinoma.
Oncologist
; 21(6): 664-5, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27256874
2.
A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer.
Clin Cancer Res
; 13(12): 3652-9, 2007 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17575230
3.
Phase I and pharmacokinetic study of pemetrexed with high-dose folic acid supplementation or multivitamin supplementation in patients with locally advanced or metastatic cancer.
Clin Cancer Res
; 13(9): 2675-83, 2007 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17473199
4.
Pemetrexed in patients with locally advanced or metastatic breast cancer who had received previous anthracycline and taxane treatment: phase II study.
Clin Breast Cancer
; 7(5): 380-5, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17239262
5.
Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer.
Clin Breast Cancer
; 6(2): 143-9, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16001992
6.
Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer.
Int J Radiat Oncol Biol Phys
; 89(2): 284-91, 2014 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24726286
7.
Phase II and gene expression analysis trial of neoadjuvant capecitabine plus irinotecan followed by capecitabine-based chemoradiotherapy for locally advanced rectal cancer: Hoosier Oncology Group GI03-53.
Cancer Chemother Pharmacol
; 70(1): 25-32, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22610353
8.
Pemetrexed plus cetuximab in patients with recurrent non-small cell lung cancer (NSCLC): a phase I/II study from the Hoosier Oncology Group.
J Thorac Oncol
; 4(11): 1420-4, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19701110
9.
Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies.
Cancer
; 95(10): 2223-9, 2002 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12412177